Fondaparinux Sodium NDC 55111-679

NDC codes

FDA NDC Directory

Product NDC (as listed)55111-679Labeler and product segments. Claims need a package NDC.

Product NDC at billing width55111-0679Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
55111-679-02	55111067902	2 SYRINGE in 1 CARTON (55111-679-02) / .4 mL in 1 SYRINGE (55111-679-11)Marketed from Jul 14, 2011
55111-679-10	55111067910	10 SYRINGE in 1 CARTON (55111-679-10) / .4 mL in 1 SYRINGE (55111-679-11)Marketed from Jul 14, 2011

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Fondaparinux Sodium
Generic name (nonproprietary): fondaparinux sodium
Active ingredients: Fondaparinux sodium — 5 mg/.4mL
Dosage form: Injection
Route: Subcutaneous
Labeler: Dr. Reddy's Laboratories Limited
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 091316
Marketing start: Jul 14, 2011
Listing expires: Dec 31, 2026
Other FDA classes: Factor Xa Inhibitors (Mechanism)
Identifiers: Product ID 55111-679_2a3f9c6b-885b-843d-9cc8-3eb67395fbdaSPL ID 2a3f9c6b-885b-843d-9cc8-3eb67395fbdaSPL set ID 49e0d7bc-3f49-849b-c77c-98682d1c0d19RxCUI 861356, 861360, 861363, 861365UNII X0Q6N9USOZ
Pharmacologic class: Factor Xa Inhibitor

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.

Administration

Drug administration (CPT 96360–96549)

When a clinician administers the drug, the administration is reported separately. Codes in this range cover hydration, therapeutic injections and infusions, and chemotherapy or other complex drug administration. The right code depends on route, duration and drug type, and self-administered drugs are not billed this way.

How CPT relates to drug billing

NDC on a medical claim

N455111067902 followed by a unit qualifier and the quantity

Package 55111-0679-02. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Label details couldn’t be retrieved right now. Open the label on DailyMed.

Other NDCs under ANDA 091316

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 091316
Product	Strength	Form · route	Labeler	Product NDC
Fondaparinux Sodium	Fondaparinux sodium 2.5 mg/.5mL	InjectionSubcutaneous	Dr. Reddy's Laboratories Limited	55111-678
Fondaparinux Sodium	Fondaparinux sodium 7.5 mg/.6mL	InjectionSubcutaneous	Dr. Reddy's Laboratories Limited	55111-680
Fondaparinux Sodium	Fondaparinux sodium 10 mg/.8mL	InjectionSubcutaneous	Dr. Reddy's Laboratories Limited	55111-681